Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
  1. 4 Open-market sale Chief Accounting Officer sold 460 shares at an average $22.39 ($10,301)
  2. 4 Grant or award Chief Financial Officer acquired 61,409 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Chief Scientific Officer acquired 15,995 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 5,899 shares (grant or award)
  7. 4 Grant or award Director acquired 5,899 shares (grant or award)
  8. 4 Grant or award Director acquired 5,899 shares (grant or award)
  9. 4 Grant or award Director acquired 5,899 shares (grant or award)
  10. 4 Grant or award Director acquired 5,899 shares (grant or award)
  11. 4 Grant or award Director acquired 5,899 shares (grant or award)
  12. 4 Grant or award Director acquired 5,899 shares (grant or award)
  13. 4 Grant or award Director acquired 5,899 shares (grant or award)
  14. 4 Grant or award Int. Chief Financial Officer acquired 13,300 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 63,452 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale President and CEO sold 5,196 shares at $47.05 ($244,472)
  19. 4 Open-market sale Chief Financial Officer sold 1,702 shares at $47.05 ($80,079)
  20. 4 Open-market sale Chief Medical Officer sold 1,699 shares at $47.05 ($79,938)

Page 4 of 15 · 285 filings